Abstract
This article gives a historical background on the introduction of the chalcogen chemistry in Brazil. It also describes the development of synthetic methods based on organotellurium compounds, and their use in the synthesis of biologically active compounds. A brief comment on the biological activity of organotellurium compounds is also made.
Keywords: Bioactive compounds, chalcogen chemistry, organic synthesis, organotellurides, tellurium/metal exchange, total synthesis.
Graphical Abstract
Current Organic Synthesis
Title:Tellurium Chemistry in Brazil: Origin and Development
Volume: 12 Issue: 5
Author(s): Cleverson Princival, Mônica F. Z. J. Amaral, Alcindo A. Dos Santos and Joao V. Comasseto
Affiliation:
Keywords: Bioactive compounds, chalcogen chemistry, organic synthesis, organotellurides, tellurium/metal exchange, total synthesis.
Abstract: This article gives a historical background on the introduction of the chalcogen chemistry in Brazil. It also describes the development of synthetic methods based on organotellurium compounds, and their use in the synthesis of biologically active compounds. A brief comment on the biological activity of organotellurium compounds is also made.
Export Options
About this article
Cite this article as:
Princival Cleverson, Amaral F. Z. J. Mônica, Dos Santos A. Alcindo and Comasseto V. Joao, Tellurium Chemistry in Brazil: Origin and Development, Current Organic Synthesis 2015; 12 (5) . https://dx.doi.org/10.2174/157017941205150821122506
DOI https://dx.doi.org/10.2174/157017941205150821122506 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Endocrine Disruptor Agent Nonyl Phenol Exerts An Estrogen-like Transcriptional Activity on Estrogen Receptor Positive Breast Cancer Cells
Current Medicinal Chemistry The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets
Anti-Cancer Agents in Medicinal Chemistry Chalcones as Promising Lead Compounds on Cancer Therapy
Current Medicinal Chemistry Stimuli-responsive Smart Liposomes in Cancer Targeting
Current Drug Targets Structural Characteristics of Short Peptides in Solution
Protein & Peptide Letters Molecular and Genetic Profiling of Prostate Cancer: Implications for Future Therapy
Current Cancer Therapy Reviews Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells
Mini-Reviews in Medicinal Chemistry Regulators of Chemokine Receptor Activity as Promising Anticancer Therapeutics
Current Cancer Drug Targets PET Studies on P-Glycoprotein Function in the Blood-Brain Barrier: How it Affects Uptake and Binding of Drugs within the CNS
Current Pharmaceutical Design Regulation of MicroRNAs by Phytochemicals: A Promising Strategy for Cancer Chemoprevention
Current Cancer Drug Targets Are the Myokines the Mediators of Physical Activity-Induced Health Benefits?
Current Pharmaceutical Design Approaches for the Inhibition of Human Telomerase Based on the Use of Peptide Nucleic Acids and Hammerhead Ribozymes
Mini-Reviews in Medicinal Chemistry Ligand Decorated Primaquine Loaded Nanocarriers for Liver Targeting for Triggered Anti-Malarial Activity
Current Molecular Pharmacology Regulation of Sulfotransferases by Xenobiotic Receptors
Current Drug Metabolism Procathepsin D as a Tumor Marker, Anti-Cancer Drug or Screening Agent
Anti-Cancer Agents in Medicinal Chemistry Medicinal Chemistry of Antiviral/Anticancer Prodrugs Subjected to Phosphate Conjugation
Mini-Reviews in Medicinal Chemistry The Protective Effects of Natural Products on Blood-Brain Barrier Breakdown
Current Medicinal Chemistry Milk Thistle: A Future Potential Anti-Osteoporotic and Fracture Healing Agent
Current Drug Targets Targeting the Atypical Chemokine Receptor ACKR3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization
Current Topics in Medicinal Chemistry Quantitative Enzymology
Current Enzyme Inhibition